Travera Overview

  • Founded
  • 2017
  • Status
  • Private
  • Employees
  • 6
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $7.8M
Latest Deal Amount
  • Investors
  • 5

Travera General Information


Developer of a measurement technology intended to measure which cancer drugs work against each individual's different cancer cells. The company's MIT technology measures cancer cell's tiny change in growth rate in a few hours using a universal biomarker in response to a cancer drug while it is still a viable cell, enabling oncologists to quickly determine which drugs to prescribe based on the actual responses of their patients' tumor cells to candidate drugs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 99A Erie Street
  • Cambridge, MA 02139
  • United States
+1 (650) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Travera Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 08-Jul-2019 $7.8M 00.00 Completed Startup
To view Travera’s complete valuation and funding history, request access »

Travera Executive Team (5)

Name Title Board Seat Contact Info
Clifford Reid Ph.D Co-Founder, Chief Executive Officer & Board Member
Scott Manalis Ph.D Co-Founder & Principal Consultant
Mark Stevens Ph.D Co-Founder & Director of Clinical Development
Selim Olcum Ph.D Co-Founder & Director of Engineering
Rob Kimmerling Ph.D Co-Founder & Director of Research & Development
To view Travera’s complete executive team members history, request access »

Travera Board Members (4)

Name Representing Role Since
Clifford Reid Ph.D Travera Co-Founder, Chief Executive Officer & Board Member 000 0000
David Margulies MD Self Board Member 000 0000
L. Robert Johnson Travera Board Member 000 0000
Patrick Zhang Horizons Ventures Board Member 000 0000
To view Travera’s complete board members history, request access »

Travera Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Travera Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Affinity Biosensors Venture Capital Minority 000 0000 000000 0
Founders Capital Partners Venture Capital Minority 000 0000 000000 0
Grey Sky Venture Partners Venture Capital Minority 000 0000 000000 0
Horizons Ventures Venture Capital Minority 000 0000 000000 0
The Leukemia & Lymphoma Society Corporation Minority 000 0000 000000 0
To view Travera’s complete investors history, request access »